Advertisement

Topics

Icagen. Omdana Therapeutics partner to advance discovery of novel medicines for pulmonary hypertension

08:31 EDT 22 Jun 2017 | PharmaBiz

Icagen and Omdana Therapeutics, have announced a collaboration to help advance the discovery of novel medicines for disorders related to tissue homeostasis and vascular remodeling such as pulmonary hypertension.

Original Article: Icagen. Omdana Therapeutics partner to advance discovery of novel medicines for pulmonary hypertension

NEXT ARTICLE

More From BioPortfolio on "Icagen. Omdana Therapeutics partner to advance discovery of novel medicines for pulmonary hypertension"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of affected individuals. Symptoms can range from mild breathles...